Evidence map›Paper›PMID 17553896›Full record

ArticleJournal of virology2007

Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection.

Lucy Golden-Mason, Nicole Castelblanco, Cliona O'Farrelly, Hugo R Rosen

Abstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Biomarkers in Detection of Hepatitis C Virus Infection.Pathogens (Basel, Switzerland) · 2024
    Review
  4. Article
  5. Natural Killer T-like Cells: Immunobiology and Role in Disease.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Lucy Golden-MasonDivision of Gastroenterology and Hepatology, Hepatitis C Center, University of Colorado at Denver Health Sciences Center, and National Jewish Hospital, Denver, Colorado, USA.
Nicole Castelblanco
Cliona O'Farrelly
Hugo R Rosen
Denver Health Medical Center · USHepatitis B Foundation · USNational Jewish Health · USSt. Vincent's University Hospital · IE

Funding

Immune Responses in Acute Hepatitis C InfectionR01DK060590 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI ROSEN, HUGO RAMON · 2002 to 2010
$2.0M
NIDDK NIH HHS R01 DK060590PHS HHS U19 A 1066328-01
6 · The paper itself

Abstract

Innate CD56(pos) natural killer (NK) and natural T (NT) cells comprise important hepatic antiviral effector lymphocytes whose activity is fine-tuned through surface NK receptors (NKRs). Dysregulation of NKRs in patients with long-standing hepatitis C virus (HCV) infection has been shown, but little is known regarding NKRs in acute infection. Treatment-naïve patients with acute HCV (n = 22), including 10 with spontaneous recovery, were prospectively studied. CD56(pos) NT levels were reduced early in acute HCV infection and did not fluctuate over time. In resolving HCV infection, NT cells with a more activated phenotype (lower CD158A and higher natural cytotoxicity receptor expression) at baseline predated spontaneous recovery. Moreover, NKG2A expression on CD56(+) NT cells correlated directly with circulating HCV RNA levels. Deficient interleukin-13 (IL-13) production by NT cells and reduced IL-2-activated killing (LAK) at baseline were associated with the ultimate development of persistence. These results indicate a previously unappreciated role for NT cells in acute HCV infection and identify a potential target for pharmacologic manipulation.

Indexed as

Acute DiseaseAdultCD56 AntigenFemaleHepacivirusHepatitis CHumansInterleukin-13Interleukin-2Killer Cells, NaturalMaleMiddle AgedNatural Cytotoxicity Triggering Receptor 1NK Cell Lectin-Like Receptor Subfamily CReceptors, ImmunologicReceptors, KIRCD56 AntigenInterleukin-13Interleukin-2KLRC1 protein, humanNatural Cytotoxicity Triggering Receptor 1NCR1 protein, humanNK Cell Lectin-Like Receptor Subfamily CReceptors, ImmunologicReceptors, KIRReceptors, KIR2DL1Receptors, Natural Killer CellRNA, Viral

Identifiers

PMID17553896
PMCPMC1951454
OpenAlexW2139246666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.